Internal Medicine, Rheumatology · Sarasota, FL
NPI
1326368689
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1945 Versailles St, 2nd Floor
Sarasota, FL, 34239
Phone (941) 365-0770
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
86,148 services
Medicare patients, 2024
650
Average age 76
Drug cost, 2024
$1.6M
2,355 prescriptions
Company payments, 2025
$6,923
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jaishree Manohar was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 27,000 times for 29 patients. In total Jaishree Manohar billed 86,148 services in 59 codes, and Medicare paid $1.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 27,000 | 29 | $3.67 | $99K |
| J3262 Injection, tocilizumab, 1 mg | Office | 19,035 | 24 | $4.72 | $90K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 12,560 | 44 | $9.25 | $116K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 7,101 | 44 | $33.61 | $239K |
| J0897 Injection, denosumab, 1 mg | Office | 4,742 | 81 | $19.68 | $93K |
| 86235 Immunoassay | Office | 1,057 | 108 | $17.55 | $19K |
| 99214 Office E&M - Established | Office | 1,051 | 387 | $90.50 | $95K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 365 | 233 | $12.90 | $4,707 |
| 86147 Immunoassay | Office | 337 | 103 | $24.87 | $8,380 |
| 86146 Immunoassay | Office | 327 | 101 | $24.74 | $8,090 |
| 36415 Venipuncture Blood Collection | Office | 258 | 194 | $8.67 | $2,237 |
| 83516 Immunoassay | Office | 242 | 107 | $11.21 | $2,712 |
| 96401 Chemotherapy Administration | Office | 231 | 141 | $51.60 | $12K |
| 96365 Intravenous Infusion, Hydration | Office | 146 | 81 | $44.80 | $6,541 |
| 96413 Chemotherapy Administration | Office | 135 | 94 | $96.17 | $13K |
By year: 2022 $2.1M for 166,400 services; 2023 $1.9M for 161,531 services; 2024 $1.1M for 86,148 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 1,057 | 108 | $17.55 | $19K |
| 86147 Immunoassay | 337 | 103 | $24.87 | $8,380 |
| 86146 Immunoassay | 327 | 101 | $24.74 | $8,090 |
| 36415 Venipuncture Blood Collection | 258 | 194 | $8.67 | $2,237 |
| 83516 Immunoassay | 242 | 107 | $11.21 | $2,712 |
| 86226 Immunoassay | 122 | 110 | $11.77 | $1,436 |
| 86431 Immunoassay | 119 | 108 | $5.51 | $656 |
| 86225 Immunoassay | 116 | 109 | $13.35 | $1,549 |
| 86200 Immunoassay | 115 | 105 | $12.58 | $1,447 |
| 86021 Immunoassay | 115 | 104 | $14.62 | $1,682 |
Medicare prescription drug claims, 2024
In 2024, the drug Jaishree Manohar prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 355 prescriptions and refills. In total Jaishree Manohar wrote 2,355 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 355 | 1,037 | 117 | $16K |
| Methotrexate Methotrexate Sodium | 315 | 803 | 98 | $9,351 |
| Prednisone Generic | 278 | 677 | 104 | $2,777 |
| Leflunomide Generic | 130 | 330 | 46 | $11K |
| Celecoxib Generic | 96 | 276 | 34 | $4,997 |
| Gabapentin Generic | 95 | 255 | 37 | $1,496 |
| Folic Acid Generic | 80 | 223 | 24 | $1,130 |
| Duloxetine Hcl Generic | 76 | 206 | 25 | $1,570 |
| Alendronate Sodium Generic | 66 | 185 | 20 | $630 |
| Leucovorin Calcium Generic | 55 | 134 | 18 | $2,412 |
| Famotidine Generic | 52 | 156 | 22 | $506 |
| Omeprazole Generic | 48 | 145 | 18 | $722 |
| Humira(Cf) Pen Adalimumab | 39 | 43 | Under 11 | $401K |
| Cevimeline Hcl Generic | 39 | 118 | 13 | $15K |
| Tizanidine Hcl Generic | 37 | 82 | 19 | $678 |
Brand drugs: 352 claims; generic drugs: 1,954 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jaishree Manohar $6,923 ($6,923 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novartis Pharmaceuticals Corporation with $3,055.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 24 | $3,055 |
| Abbvie Inc. ABBV | 23 | $922 |
| Janssen Biotech, Inc. JNJ | 16 | $596 |
| Amgen Inc. AMGN | 14 | $392 |
| UCB, Inc. UCB.BR | 13 | $331 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $280 |
| GlaxoSmithKline, LLC. GSK | 9 | $268 |
| Pfizer Inc. PFE | 5 | $225 |
| Lilly USA, LLC LLY | 3 | $152 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.